AzTrials
AzTrials

Weight LossNCT03221543

Resting Metabolic Rate Testing in Bariatric Surgery Patients

A study testing ReeVue Indirect Calorimeter in people with Weight Loss and Bariatric Surgery Candidate, run by Baylor Research Institute at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

This study evaluates if measuring resting metabolic rate (the number of calories the body burns at rest) before surgery can help predict successful weight loss after surgery. Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Weight Loss, Bariatric Surgery Candidate
What is being tested?
ReeVue Indirect Calorimeter
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
84 participants
Where
1 siteUnited States
Study dates
31 Jul 2017to 25 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • All patients scheduled for a primary bariatric surgery
  • 18 years of age to no upper limit

Who cannot join

None listed.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Baylor Weight Loss Surgery Center

    Dallas, Texas, 75231

Other trials in United States

About this study

Official title: The Role of Pre-Surgical Metabolic Testing for Procedure Selection in Bariatric Surgery

This study evaluates if measuring resting metabolic rate (the number of calories the body burns at rest) before surgery can help predict successful weight loss after surgery.

Read the detailed description

This is a prospective study enrolling patients from the Baylor Weight Loss Surgery Center who have met all of the requirements to proceed with primary bariatric surgery. Patients will undergo pre-operative and post-operative metabolic testing (6 months, and 1 year after surgery) using a portable calorimeter with eventual follow up of medical record at 5 years. Data from up to 50 patients will be collected. The main objectives are to examine if the pre-operative resting metabolic rate can accurately predict successful weight loss after bariatric surgery and if it can be used to guide the selection of the type of bariatric surgery that would be most successful for the patient.

Being tested
ReeVue Indirect Calorimeter
Medical subject headings
Weight Loss

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ReeVue Indirect CalorimeterDevice

    The ReeVue Indirect Calorimeter will be used in this study to measure the resting metabolic rate. The test takes approximately ten minutes to complete. The subject should prepare for the test by avoiding stimulants and exercise on the day of the test, as well as eating meals four hours before the test. The subject will be seated during the test. They will be given a nose clip that looks like a clothes pin to be placed on their nose. A plastic mouth piece that allows all of the air they breathe to come in through the top of the mouth piece and the air they breathe out to go into the ReeVue Calorimeter will also be provided. The subject will remain in this position for ten minutes until the testing is complete.

Study groups in NCT03221543
Study groupRoleWhat they receive
Resting Metabolic Rate TestingExperimentalAll subjects will have the resting metabolic rate test. The ReeVue Indirect Calorimeter from Korr Medical will be used to obtain the resting metabolic rate.
Receives: Device: ReeVue Indirect Calorimeter

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Examine percent total weight loss

    Weigh subjects using a scale

    Measured: 1 year

Secondary outcomes (1)
  1. Change in resting metabolic rate

    Obtain resting metabolic rate using the Reevue Indirect Calorimeter

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jul 2017
  2. Study start31 Jul 2017
  3. Primary completion25 Jun 2023
  4. Study completion25 Dec 2023

Why it stopped: In this study, there is 1 year of active subject participation and long-term follow-up data collected at year 5. Since study objectives were met with active subject data, the study team will not be collecting long-term data at year 5.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
84 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03221543
Sponsor's protocol ID
IRB 017-125
Status last verified
Jan 2026
First submitted
12 Jul 2017
Last updated
26 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes

Questions about this trial

What is this clinical trial studying?

A study testing ReeVue Indirect Calorimeter in people with Weight Loss and Bariatric Surgery Candidate, run by Baylor Research Institute at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 26 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: In this study, there is 1 year of active subject participation and long-term follow-up data collected at year 5. Since study objectives were met with active subject data, the study team will not be collecting long-term data at year 5.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Examine percent total weight loss (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in